Oppenheimer Asset Management Inc. Laboratory Corp Of America Holdings Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$209.01 - $232.56 $136,692 - $152,094	-654 Reduced 6.42%	9,540 $2.08 Million
Q4 2023 Feb 13, 2024	SELL	$197.69 - $227.29 $65,435 - $75,232	-331 Reduced 3.14%	10,194 $2.32 Million
Q3 2023 Nov 07, 2023	BUY	$201.05 - $221.7 $285,491 - $314,814	1,420 Added 15.6%	10,525 $2.12 Million
Q2 2023 Aug 02, 2023	BUY	$211.93 - $241.33 $132,032 - $150,348	623 Added 7.34%	9,105 $2.2 Million
Q1 2023 May 10, 2023	SELL	$213.32 - $257.83 $108,793 - $131,493	-510 Reduced 5.67%	8,482 $1.95 Million
Q4 2022 Feb 06, 2023	BUY	$203.72 - $248.97 $1.29 Million - $1.57 Million	6,323 Added 236.91%	8,992 $2.12 Million
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $35,227 - $45,096	172 Added 6.89%	2,669 $546,000
Q2 2022 Aug 08, 2022	SELL	$213.86 - $277.87 $48,332 - $62,798	-226 Reduced 8.3%	2,497 $585,000
Q1 2022 May 12, 2022	BUY	$259.82 - $298.18 $34,815 - $39,956	134 Added 5.18%	2,723 $718,000
Q4 2021 Feb 02, 2022	BUY	$271.6 - $314.21 $3,802 - $4,398	14 Added 0.54%	2,589 $814,000
Q3 2021 Nov 12, 2021	BUY	$274.82 - $308.34 $64,033 - $71,843	233 Added 9.95%	2,575 $724,000
Q2 2021 Aug 03, 2021	BUY	$251.87 - $278.14 $55,411 - $61,190	220 Added 10.37%	2,342 $646,000
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $113,503 - $141,286	-554 Reduced 20.7%	2,122 $541,000
Q4 2020 Feb 11, 2021	BUY	$186.91 - $214.42 $1,121 - $1,286	6 Added 0.22%	2,676 $545,000
Q3 2020 Nov 13, 2020	SELL	$167.03 - $201.3 $32,069 - $38,649	-192 Reduced 6.71%	2,670 $502,000
Q2 2020 Aug 11, 2020	SELL	$113.31 - $182.44 $41,924 - $67,502	-370 Reduced 11.45%	2,862 $476,000
Q1 2020 May 08, 2020	SELL	$104.32 - $195.28 $16,482 - $30,854	-158 Reduced 4.66%	3,232 $407,000
Q4 2019 Feb 07, 2020	SELL	$163.48 - $173.61 $817 - $868	-5 Reduced 0.15%	3,390 $574,000
Q3 2019 Oct 31, 2019	BUY	$159.77 - $178.1 $46,333 - $51,649	290 Added 9.34%	3,395 $570,000
Q2 2019 Aug 09, 2019	BUY	$144.16 - $172.9 $20,903 - $25,070	145 Added 4.9%	3,105 $537,000
Q1 2019 Apr 24, 2019	BUY	$123.7 - $156.3 $50,964 - $64,395	412 Added 16.17%	2,960 $453,000
Q4 2018 Jan 30, 2019	BUY	$120.82 - $174.09 $78,049 - $112,462	646 Added 33.96%	2,548 $322,000
Q3 2018 Oct 26, 2018	BUY	$167.67 - $188.27 $31,354 - $35,206	187 Added 10.9%	1,902 $331,000
Q2 2018 Aug 10, 2018	BUY	$160.33 - $189.41 $8,337 - $9,849	52 Added 3.13%	1,715 $308,000
Q1 2018 May 09, 2018	BUY	$161.53 - $178.11 $28,913 - $31,881	179 Added 12.06%	1,663 $269,000
Q3 2017 Nov 14, 2017	BUY	$149.47 - $160.56 $221,813 - $238,271	1,484	1,484 $224,000

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account